(Q33340268)
Statements
1 reference
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks (English)
1 reference
Sharma S
1 reference
Kemeny N
1 reference
Schwartz GK
1 reference
Kelsen D
1 reference
O'Reilly E
1 reference
Ilson D
1 reference
Coyle J
1 reference
De Jager RL
1 reference
Ducharme MP
1 reference
Kleban S
1 reference
Hollywood E
1 reference
Saltz LB
1 reference
1 December 2001
1 reference
1 reference
12
1 reference
3963-3970
1 reference
Identifiers
1 reference